Skip to content

Drug interactions

Asenapine + Encorafenib

Severity: Major

Asenapine and Encorafenib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encorafenib can prolong the QTc interval in a dose-dependent manner, and asenapine has a similar effect. Used together they may increase the risk of torsades de pointes.

What this interaction means in plain words

Asenapine and Encorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Asenapine belongs to Central Nervous System; Encorafenib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT interval prolongation.

What to do

Avoid the combination where possible. If it is needed, monitor ECG and electrolytes at baseline and periodically, and reduce or withhold encorafenib if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Asenapine and Encorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Asenapine with Encorafenib?

MediHelp rates the interaction as major. Asenapine and Encorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Encorafenib can prolong the QTc interval in a dose-dependent manner, and asenapine has a similar effect. Used together they may increase the risk of torsades de pointes.

How serious is the interaction between Asenapine and Encorafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If it is needed, monitor ECG and electrolytes at baseline and periodically, and reduce or withhold encorafenib if QTc becomes markedly prolonged.

What other medicines interact with Asenapine?

MediHelp also lists interactions of Asenapine with, for example, Pimozide, Thioridazine, Vandetanib. The full list is on the Asenapine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in